Open access · OA
via Europe PMC
Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications.
Li H, Wang N, Ran X, Fan Z, Zhao T, Ma X.
Frontiers in endocrinology · 2026
Abstract
Thyroid hormones are involved in multiple metabolic pathways in the body and are essential for maintaining organ functions across the lifespan. Aging-related thyroid dysfunction has a bidirectional relationship with the development of chronic diseases including metabolic syndrome, diabetes, and cardiovascular disease, and contributes to the progression of cardiovascular-kidney-metabolic (CKM) syndrome via complex pathophysiological mechanisms. Systematically elaborating on the characteristics of thyroid function related to aging and its regulatory role in metabolism and cardiovascular homeostasis, can provide new therapeutic strategies and theoretical basis for revealing the molecular network and metabolic process of the CKM syndrome. In this review, we have summarized the manifestations of thyroid hormone homeostasis in age-related changes, and the underlying potential mechanisms during aging and longevity processes. Moreover, we systematically elucidated the pivotal role of thyroid hormones in cardiovascular and renal homeostasis, discussed the interplay between thyroid dysfunction and metabolic risk factors in CKM syndrome, particularly issues related to obesity, type 2 diabetes, and dyslipidemia. Patients with thyroid dysfunction develop CKM syndrome through a positive feedback loop centered on metabolic disorders and organic dysfunction. Moreover, we pointed out that novel drugs targeting thyroid hormone receptors are expected to slow down the progression of CKM syndrome and reduce cardiovascular risks.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fendo.2026.2000192
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
H, L., N, W., X, R., Z, F., T, Z., & X., M. (2026). Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications. <em>Frontiers in endocrinology</em>. https://doi.org/10.3389/fendo.2026.2000192
Vancouver
H L, N W, X R, Z F, T Z, X. M. Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications. Frontiers in endocrinology. 2026. doi:10.3389/fendo.2026.2000192.
BibTeX
@article{li2026Thyroi,
title = {Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications.},
author = {Li H and Wang N and Ran X and Fan Z and Zhao T and Ma X.},
journal = {Frontiers in endocrinology},
year = {2026},
doi = {10.3389/fendo.2026.2000192},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Acta Pharmaceutica Sinica B 2021
Open access · CC-BY
The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
Diabetologia 2008
Open access · OA
Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease
Basic & clinical pharmacology & toxicology 2026
Open access · OA
The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective.
Cardiology Clinics 2004
Citation only
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications
Ageing Research Reviews 2025
Open access · CC-BY
Liver X receptors and the hallmarks of aging: From molecular mechanisms to therapeutic opportunities
International journal of molecular sciences 2026
Citation only